Ir high dose rate source used in brachytherapy treatment of cervical cancer ABSTRACT Purpose: The study purpose included dosimetric comparison of cobalt 60 ( 60 Co) and iridium 192 ( 192 Ir) high dose rate (HDR) source used in brachytherapy treatment of cervical cancer.
INTRODUCTION
Cancer of the uterine cervix is one of the most common malignancies that have been treated effectively with radiotherapy in countries with low and medium human development index. [1] A combination of external beam treatment with brachytherapy is used to increase the dose to the tumor with reduced dose to the organs at risk. [2] It has proven to be a successful treatment for cancers of the prostate, cervix, esophagus, and head and neck and several other types of cancer. [3] High dose rate (HDR) brachytherapy is widely accepted for cervical cancer treatment. [4] One of its advantages over low dose rate (LDR) treatment is the possibility to treat more patients, which is better in centers with the large turnout of patients but with limited facilities. [5] Iridium 192 ( 192 Ir) source is used widely for HDR brachytherapy. This is because it is easier to manufacture in a smaller size for brachytherapy applications. The smaller size of the sources allowed interstitial treatment and dose optimization. [6] In recent times, the use of cobalt 60 ( 60 Co) sources has increased because of its longer half-life and its availability in the miniaturized form (with dimensions comparable to those of 192 Ir HDR sources) for HDR brachytherapy applications. The use of physically larger 60 Co source in LDR applications has a long history, and it was available 
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. in pellet and needle forms. [7, 8] The longer half-life (5.26 years) of 60 Co source compared to 192 Ir (73.8 days) implies that instead of changing the 192 Ir source every 3-4 months, 60 Co source can be changed every 6-8 years; it is lot more economical and attractive for low-resource settings especially in developing countries in view of the available infrastructure. Due to the high energy of 60 Co (average energy = 1.25 MeV) than 192 Ir (average energy = 0.38 MeV), the 60 Co-based brachytherapy machines require more shielding. The 60 Co source offers logistical and economic advantages over 192 Ir source, resulting in reduced operating cost. [9] [10] [11] No clinically significant differences were shown using 60 Co source in intracavitary brachytherapy compared to 192 Ir. The isodose distribution was also not significantly different when dwell time optimization technique was used. [12] [13] [14] In the present study, the three-dimensional dosimetric comparison of computed tomography (CT)-based treatment plans was done as per the International Commission on Radiation Unit (ICRU)-89 guidelines using 60 Co and 192 Ir HDR sources in intracavitary brachytherapy.
MATERIALS AND METHODS
The retrospective dosimetric study for 15 patients treated with 60 Co HDR source has been considered for the present study. The 60 Co (3.5 mm active length, 0.5 mm active diameter, Model-Co0. A86, Eckert and Ziegler, Bebig, Germany) and 192 Ir (3.5 mm active length, 0.6 mm active diameter, Model-Ir2.A85-2, Eckert and Ziegler, Bebig, Germany) HDR sources were used for the dosimetric comparative study. A Bebig Multisource ® HDR brachytherapy unit and treatment planning system HDR 2.5 plus (Eckert and Ziegler, Bebig, Germany) were used for the study.
All the patients were treated with a standard dose of external beam radiotherapy, followed by HDR brachytherapy with three fractions of 7 Gy per fraction per week as per institutional protocol. Brachytherapy application was done under general anesthesia after getting pre-anesthetic clearance in the lithotomy position. A Foley's catheter was inserted into the urinary bladder, and the balloon was inflated with 7 cc of diluted urograffin dye to identify the bladder reference points. Fletcher suite applicators were used for brachytherapy in all the patients. The suitable tandem and ovoids were placed as per the geometry of the patient. The vagina was packed with gauze to displace the bladder further anteriorly and the rectum posteriorly to minimize the dose to these organs and to immobilize the applicators.
Structure delineation and treatment planning
The CT scans for all the patients were taken with 3-mm slice thickness. The contouring of high-risk clinical target volume (HRCTV), bladder, and rectum on CT images was contoured as per the GEC ESTRO guidelines and ICRU 89 guidelines with the help of magnetic resonance imaging and the dose prescription (7 Gy) to Point A. [15] [16] [17] The three-dimensional doses were calculated using a 60 Co source with 2.5 mm step size as per the TG-43 protocol. [18] The study was carried out using 192 Ir source by keeping all the parameters same such as applicator reconstruction, dwell position, step size, dose prescription, and dose calculation. The dose-volume parameters such as D 50 (Gy), D 90 (Gy), and D 98 (Gy) for HRCTV were calculated using 60 Co and 192 Ir HDR sources. The volumetric doses such as D 0.1cc (Gy), D 1cc (Gy), D 2cc (Gy), and D 5cc (Gy) to the bladder and rectum were calculated for both the HDR sources. ICRU bladder and rectum reference points were also calculated and compared.
We used the two-sample t-test for data analysis. The threshold for statistical significance was kept at P < 0.05. Figure 1 shows the isodose distribution in a coronal view of a typical patient with 192 Ir source (left side) and 60 Co source (right side). The right side shows isodose line bulge out compared to the left side in cranial-caudal direction. The length at 50% isodose line in cranial-caudal direction was 10.8 mm (12.45%) more for 60 Co source compared to 192 Ir source. Figure 2 shows the isodose distribution in the sagittal view. The isodose line calculated by 60 Co source (right side) is more bulge out in cranial-caudal direction compared to 192 Ir source (left side). was −0.58%, −0.67%, −0.99%, −0.94%, and −1.75%, respectively. On the other hand, dose difference for D 0.1cc , D 1cc , D 2cc , D 5cc , and ICRU reference points of rectum was 0.67%, 0.26%, 0.56%, 0.63%, and −0.33%, respectively.
RESULTS
The P values of DVH parameters of HRCTV, bladder, and rectum were not found to be statistically significant (P ≥ 0.05).
DISCUSSION
In the clinical practice of intracavitary HDR brachytherapy,
192
Ir has been used because of its high specific activity and finite size. The 60 Co has also provided the same finite size with a reasonably high specific activity. Due to high energy, the treatment unit and treatment room require more shielding. The half-value layer value for 60 Co of lead is 12 mm compared to 3 mm of 192 Ir, which is four times larger. Sinnatamby et al. [19] dosimetrically compared 192 Ir and 60 Co of HDR brachytherapy for breast cancer implants and showed nearly identical dose distribution and statistically significant differences in DVH parameters, which can be reduced by treatment planning optimization but there is no advantage or disadvantage for 60 Co compared to 192 Ir with respect to clinical aspect.
The study done by Richter et al. [20] has compared the physical properties of 60 Co and 192 Ir HDR sources. This study demonstrated that the integral dose due to radial dose fall-off is higher for 192 Ir than for 60 Co within the first 22 cm from the source. At larger distances, this relationship is reversed. Their study suggests that no advantage or disadvantage exists for 60 Co sources compared with 192 Ir sources with regard to clinical aspects. However, there are potential logistical advantages of 60 Co sources because only 33% of the activity of 192 Ir sources is needed to yield an equivalent dose rate.
The results obtained in our study for intracavitary brachytherapy based on ICRU 89 guidelines when compared to those of previous studies confirm that 60 Co and 192 Ir HDR sources are comparable in terms of DVH parameters. The Co source-based HDR brachytherapy unit is a good choice especially in centers with small number of brachytherapy procedures as no frequent source replacement is required like an 192 Ir-based HDR brachytherapy that reduces the cost of brachytherapy treatment.
CONCLUSIONS
The present study results show that all the dose parameters of HRCTV, bladder, and rectum with 60 Co are comparable with those of 192 Ir HDR source. All the DVH parameters are within 2% except D 50 of HRCTV (3.19%), which is less than the uncertainty level reported by Kirisits et al. [21] for intracavitary brachytherapy. Dosimetrically, no advantage or disadvantage exists for 60 Co compared to 192 Ir source. The P values of DVH parameters of HRCTV, bladder, and rectum were not found to be statistically significant. The isodose distribution more bulge out for 60 Co in cranial-caudal direction compared to 192 Ir. However, these differences can be reduced by treatment planning optimization techniques. The miniaturized 60 Co source can be used for HDR intracavitary brachytherapy because of logistic and financial benefits due to the longer half-life. The clinical plan evaluation in each slice and plane is necessary to explore the advantages of 60 Co source over 192 Ir HDR source.
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